Corporate finance has advanced a great deal in the analysis of conventional companies, known as the great value that is evidenced in the value of organizations, whether to apply them in cases of mergers, acquisitions, management orientation of performance or more causes. Regarding the analysis of XxxxxxXxxx, a small, limited liability company acting in the wake of medical correlates, conventional forms of company analysis are applicable, but the current literature on both finance and accounting does not address the peculiarities of the industry. The urgency of scientific and academic material that addresses the analysis and perception of sector institutions is clear given the great strategic economic importance of the sector, however little explored. The presented monograph seeks to allow at least the first steps to correct the analysis of conventional companies from the point of view of value for the sector to which it is inserted. The research presents the main analytical techniques of companies, the peculiarities of the medical correlates sector in comparison to conventional companies, the recognition of the main value vectors of the commercial industries and the assertion of a model of production of discounted cash movement to reach the intrinsic value. After demonstrating this model, it was refined to tests in data passed by the company itself to affirm its applicability.